Søgning på udtrykket 'mycoplasma' giver 41 resultater
Dokumenter [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [1]
1. udgave, forventes opdateret i løbet af 2022. Retningslinjerne er udarbejdet af en arbejdsgruppe med repræsentanter fra Dansk Lungemedicinsk Selskab og Dansk Selskab for Infektionsmedicin.
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?BMC Infectious Diseases
14.09.2024
. Abstract. . Background. X-linked agammaglobulinemia (XLA), also referred to as Bruton’s tyrosine kinase deficiency, is a rare genetic disorder that affects the immune system. We conducted genetic analysis on patients suffering from immunodeficiency by utilizing Next-Generation Sequencing techniques, as well as their closest relatives, to facilitate accurate diagnosis, offer genetic counseling services, and enhance our co…
BMC Infectious Diseases
6.09.2024
. Abstract. . Background. The clinical significance of the presence or absence of Mycoplasma pneumoniae (MP) in pleural effusion in Mycoplasma pneumoniae pneumonia (MPP) children has not yet been elucidated. Herein, we investigated the clinical implication of pleural fluid MP positive in children with MPP. . . . Methods. A total of 165 MPP c…
Infection and Immunity
13.08.2024
Infection and Immunity, Ahead of Print.
International Journal of Infectious Diseases
6.08.2024
Respiratory infections represent a significant burden on global public health, contributing to substantial morbidity and mortality worldwide. These infections encompass a spectrum of illnesses affecting the upper and lower respiratory tract, often resulting in severe complications, hospitalizations, and increased healthcare expenditure. Among the causative agents, M. pneumoniae stands out due to its notable roles in causing respiratory tract infections, ranging from mild respiratory symptoms to severe pneum…
BMC Infectious Diseases
1.08.2024
. Abstract. . Background. The global prospective surveillance data showed the re-emergence of mycoplasma pneumoniae pneumonia (MPP) in Europe and Asia after the coronavirus disease 2019 pandemic. We sought to observe the effect of macrolide antibiotics in the treatment of MPP carrying a macrolide-resistant mutation gene and the potential of targeted next-generation sequencing (tNGS) as a front-line diagnostic in MPP patients…
BMC Infectious Diseases
19.07.2024
. Abstract. . Background. The prevalence and severity of pediatric Mycoplasma pneumoniae pneumonia (MPP) poses a significant threat to the health and lives of children. In this study, we aim to systematically evaluate the value of routine blood parameters in predicting MPP and develop a robust and generalizable ensemble artificial intelligence (AI) model to assist in identifying patients with MPP. . . …
Infection
10.07.2024
BMC Infectious Diseases
4.07.2024
. Abstract. . Background. An improper host immune response to Mycoplasma pneumoniae generates excessive inflammation, which leads to the impairment of pulmonary ventilation function (PVF). Azithromycin plus inhaled terbutaline has been used in the treatment of Mycoplasma pneumoniae pneumonia (MPP) in children with impaired pulmonary function, but previous randomized controlled trials (RCTs) showed inconsistent efficacy and s…
Infection
2.07.2024
BMC Infectious Diseases
30.06.2024
. Abstract. . Background. An improper host immune response to Mycoplasma pneumoniae generates excessive inflammation, which leads to the impairment of pulmonary ventilation function (PVF). Azithromycin plus inhaled terbutaline has been used in the treatment of Mycoplasma pneumoniae pneumonia (MPP) in children with impaired pulmonary function, but previous randomized controlled trials (RCTs) showed inconsistent efficacy and s…
Emerg Microbes Infect
28.06.2024
Volume 13, Issue 1, December 2024 .
BMC Infectious Diseases
12.06.2024
… The impact of chickens on maintaining the economy and livelihood of rural communities cannot be overemphasized. In recent years, mycoplasmosis has become one of the diseases that affect the success of South African chicken production. Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are the most prevalent strains of Mycoplasma in South Africa. MG and MS are significant respiratory pathogens affecting the productivity of chickens. The present study aimed to molecularly detect u…
Clinical Infectious Diseases
7.06.2024
Abstract . Background . Differences in opinion concerning the contribution of M. genitalium to pelvic inflammatory disease (PID) has resulted in inconsistencies across global testing and treatment guidelines. We conducted a systematic review and meta-analysis to determine the association between M. genitalium and PID and M. genitalium positivity within PID cases to provide a contemporary evidence base to inform clinical practice (PROSPERO registration: CRD42022382156).Methods . PubMed, Embase, Medline and W…
BMC Infectious Diseases
5.06.2024
… The impact of chickens on maintaining the economy and livelihood of rural communities cannot be overemphasized. In recent years, mycoplasmosis has become one of the diseases that affect the success of South African chicken production. Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are the most prevalent strains of Mycoplasma in South Africa. MG and MS are significant respiratory pathogens affecting the productivity of chickens. The present study aimed to molecularly detect u…
BMC Infectious Diseases
2.06.2024
…e acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have suppressed the spread of other respiratory viruses during the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to explore the epidemiological trends and clinical characteristics of Mycoplasma pneumoniae (MP) infection among inpatient children with lower respiratory tract infection (LRTI) before and during the COVID-19 pandemic, and investigate the long-term effects of China’s NPIs against COVID-19 on the epidemiology of MP among in…
Clinical Microbiology and Infection
11.05.2024
We read with interest the comment by Zayet et al. [1] to our paper recently published into Clinical Microbiology Infection concerning the unexpected increase of severe Mycoplasma pneumoniae pneumonia in Southern Switzerland [2]. In this regard, some points of our paper should be better described.
International Journal of Infectious Diseases
10.05.2024
The sharp increase in mycoplasma pneumoniae (MP) infection among children in mainland China in 2023 has raised concerns about a traditional infectious disease epidemic[1]. However, it is still impossible to accurately judge the epidemic scale, the infected objectives and the clinical outcome[2]. Until the mid-2023, strong regional epidemics occurred in northern China, mycoplasma pneumoniae pneumonia (MPP) in children attracted the attention of the World Health Organization[3].
BMC Infectious Diseases
27.04.2024
. Abstract. . Objectives. The increasing prevalence of severe Mycoplasma pneumoniae pneumonia (SMPP) poses a significant threat to the health of children. This study aimed to characterise and assess the outcomes in children with SMPP. . . . Methods. We retrospectively analysed children hospitalised for M. pneumoniae pneumonia (MPP) between J…
Infection
26.04.2024
. Abstract. . Background. Mycoplasma genitalium (MG) is an emerging sexually transmitted infection, often harboring resistance-associated mutations to azithromycin (AZM). Global surveillance has been mandated to tackle the burden caused by MG, yet no data are available for Austria. Thus, we aimed to investigate the prevalence of MG, disease characteristics, and treatment outcomes at the largest Austrian HIV—and STI clinic. . …
Infection
22.04.2024
. Abstract. . Background. Mycoplasma genitalium (MG) is an emerging sexually transmitted infection, often harboring resistance-associated mutations to azithromycin (AZM). Global surveillance has been mandated to tackle the burden caused by MG, yet no data are available for Austria. Thus, we aimed to investigate the prevalence of MG, disease characteristics, and treatment outcomes at the largest Austrian HIV—and STI clinic. . …
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Morbidity and Mortality Weekly Report (MMWR)
22.02.2024
This report describes an increase in Mycoplasma pneumoniae, a common cause of respiratory illness, beginning in fall 2023.
Eurosurveillance latest updates
16.02.2024
. Background. Antimicrobial resistance (AMR) of Mycoplasma genitalium (MG) is a growing concern worldwide and surveillance is needed. In Belgium, samples are sent to the National Reference Centre of Sexually Transmitted Infections (NRC-STI) on a voluntary basis and representative or robust national AMR data are lacking. . . Aim. We aimed to estimate the occurrence of resistant MG in Belgium. . . Methods. Between July and November 2022, frozen remnants of MG-positive samples from 21 Belgian laboratorie…
Eurosurveillance latest updates
26.01.2024
Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especial…
Eurosurveillance latest updates
12.01.2024
We report a surge of patients, especially children and adolescents, with respiratory disease caused by Mycoplasma pneumoniae in Denmark since October 2023. While the surge has reached an epidemic level, no impact on hospital capacity has been observed; only 14% (446/3,195) of cases, primarily adults, required hospitalisation. Macrolide resistance was detected in less than 2% of samples tested. Timely monitoring of hospitalisations linked to M. pneumoniae infections has been established to inform the healthc…
Statens Serum Institut
29.11.2023
Der har siden sommeren været en stigning i antallet af luftvejsinfektioner med Mycoplasma pneumoniae, og forekomsten har nu nået et epidemisk niveau med væsentlig flere tilfælde end normalt.
ProMED
11.03.2023
…l Disease -- United StatesThe Wyoming Game and Fish Department, in collaboration with the Wyoming State Veterinary Laboratory, is investigating a rare disease outbreak in pronghorn in western Wyoming.Game and Fish is estimating that approximately 200 animals have died since mid-February [2023], centered around the southern end of the Mesa south of Pinedale. Preliminary lab results identify _Mycoplasma bovis_ as the pathogen causing the mortalities._M. bovis_ should not be confused with _Mycobacterium bovis_
ProMED
1.02.2023
Other Animal Disease -- New ZealandA review of the cluster of farms infected with cattle disease _Mycoplasma bovis_ in Mid-Canterbury has ruled it could be spreading via airborne transmission. The Ministry for Primary Industries (MPI) has released the findings of an independent review into _M. bovis_ infection in Wakanui near Ashburton. MPI, Dairy NZ, and Beef & Lamb New Zealand ordered the review in mid-2022 after it became apparent infection was circulating in a small geographical area despite the use of …
ProMED
24.10.2022
Other Animal Disease -- New Zealand
ProMED
10.10.2022
Other Animal Disease -- New Zealand
ProMED
27.09.2022
Other Animal Disease -- New Zealand
ProMED
22.06.2022
Other Animal Disease -- New Zealand
Eurosurveillance latest updates
12.05.2022
. Background. Mycoplasma pneumoniae respiratory infections are transmitted by aerosol and droplets in close contact. . . Aim. We investigated global M. pneumoniae incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March 2020. . . Methods. We surveyed M. pneumoniae detections from laboratories and surveillance systems (national or regional) across the world from 1 April 2020 to 31 March 2021 and compared them with cases from corresponding months between 20…
Eurosurveillance latest updates
7.04.2022
…tted infections (STIs), we need reliable prevalence estimates. . . Aim. One objective of the Slovenian National Survey of Sexual Lifestyles, Attitudes and Health was to estimate the prevalence of STIs with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis. . . Methods. Data were collected between October 2016 and July 2017 in a probability sample of the general population aged 18–49 years. Computer-assisted face-to-face interviewing and self-completi…
Statens Serum Institut
12.10.2016
For anden efterårssæson i træk er der tegn til en epidemi med Mycoplasma pneumoniae (MP).
Statens Serum Institut
9.03.2016
Siden efteråret 2015 har der været en landsdækkende Mycoplasma pneumoniae-epidemi, EPI-NYT 49/15.
Statens Serum Institut
6.01.2016
Resistens med behandlingssvigt efter moxifloxacin behandling af M. genitalium ses i stigende grad, særligt hos patienter, som har erhvervet infektionen i Sydøstasien eller Australien.
Eurosurveillance latest updates
9.08.2024
Since November 2023, the absolute number of attendances at emergency departments for pneumonia among children aged 5–14 years in England have been above expected levels for the time of year. This increased signal peaked during March 2024 but then persisted into early summer 2024 despite decreases in prevalence of seasonal respiratory pathogens. Record linkage between emergency department and laboratory databases points to this unusual activity being driven largely by Mycoplasma pneumoniae. .
Morbidity and Mortality Weekly Report (MMWR)
22.02.2024
This report describes an increase in Mycoplasma pneumoniae, a common cause of respiratory illness, beginning in fall 2023.
Eurosurveillance latest updates
16.02.2024
. Background. Antimicrobial resistance (AMR) of Mycoplasma genitalium (MG) is a growing concern worldwide and surveillance is needed. In Belgium, samples are sent to the National Reference Centre of Sexually Transmitted Infections (NRC-STI) on a voluntary basis and representative or robust national AMR data are lacking. . . Aim. We aimed to estimate the occurrence of resistant MG in Belgium. . . Methods. Between July and November 2022, frozen remnants of MG-positive samples from 21 Belgian laboratorie…
Eurosurveillance latest updates
26.01.2024
Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especial…